Treatment

The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing. 

Evento SONEPSYN / ISSUP Chile: Chemsex

Event Date
 - 
Santiago
Chile
Este lunes 11 de julio, a las 20:00 hrs. se realizará la reunión académica del Grupo de Trabajo de Adicciones de Sonepsyn, junto a ISSUP-Chile.
ISSUP Chile

New Psychoactive Substances (NPS) Webinar Series

Video and audio recordings
Various NPS have significantly changed the picture of drug use in different countries. They are now very prominent in the drug market. Indeed, many of these substances are intended to circumvent drug laws and are sold as ‘legal’...

Highlights from the 2022 UNODC World Drug Report: Implications for drug prevention, treatment and care responses

Event Date
 - 
Vienna
Austria

ISSUP presented a webinar on Thursday, July 7, 2014, featuring Giovanna Campello, Chief of the Prevention, Treatment and Rehabilitation Section, United Nations Office on Drugs and Crime (UNODC) presenting highlights from the 2022 edition of the UNODC World Drug Report. The presentation included implications on drug prevention, treatment and rehabilitation responses during times of crisis.

The prevalence of comorbid serious mental illnesses and substance use disorders in prison populations: a systematic review and meta-analysis

Scientific article
 - 
Comorbid mental illnesses and substance use disorders are associated with adverse criminal, social, and health outcomes. Yet, their burden is not reliably known among prison populations. We therefore aimed to estimate the prevalence of comorbid serious mental illnesses and substance use disorders (dual disorders) among people in prison worldwide.